Endocrine Neoplasia

Adrenal Gland/Adrenocortical Basket Trials (Multiple Types) Biliary Tract/Gall Bladder/Cholangiocarcinoma (GI) Bladder/Urothelial (GU) Bone Metastases Brain and Central Nervous System (CNS) Breast Cervical (GYN) Colon/Rectal/Anal (GI) Endocrine Cancers Endocrine Neoplasia Esophageal (GI) Gastric/Stomach (GI) Gastrointestinal (GI) (Multiple Types) General Solid Tumors (Multiple Types) GenitoUrinary (GU) (Multiple Types) GEP-NET (NEC) GI Stromal Tumor (GIST) Gynecologic (GYN) (Multiple Types) Head and Neck Cancers Hepatocellular/Liver (GI) Hodgkins Lymphoma Insulinoma Kidney/Renal Cell Carcinoma (GU) Leukemias Lung Lymphomas Melanoma/Skin Cancers Mesothelioma Multiple Myeloma NeuroBlastoma NeuroEndocrine (NEC) (Multiple Types) NeuroEndocrine Carcinoma (NEC) Osteosarcoma Ovarian Ovarian/Primary Peritoneal (GYN) Pancreatic (GI) Paraganglioma (NEC) Penile (GU) Pheochromocytoma (NEC) Prostate (GU) Salivary Gland Sarcoma Synovial Carcinoma Testicular (GU) Thymoma Thyroid Unknown Primary Cancers Uterine (GYN) Vulvar (GYN)

Last Updated: Wed Jul 17 2024

Study Status

Enrolling

On Hold

Not Enrolling

Unknown

NCT04214353

Effect of Androgen Deprivation Therapy on Uptake of PSMA Ligand in Patients With Salivary Duct Carcinoma: an Explorative Study.

Explorative study, which evaluates the effect of androgen deprivation therapy (ADT) on the PSMA ligand uptake on 68Ga-PSMA-PET/CT in salivary duct carcinoma patients.

NCT04979611

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

The small insulinoma can not be detected by the CT or MRI. We use 68Ga-NOTA-exendin-4 positron emission tomography/computed tomography (PET/CT) to detect the insulinoma for the patient diagnosed with endogenous hyperinsulinemic hypoglycaemia. And the diagnostic value will be performed. A single dose of 37-111 Mega-Becquerel (MBq) 68Ga-NOTA-exendin-4 will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.

NCT05581979

SMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers

The objectives of this pilot feasibility study, which is on the use of 68-Ga PSMA PET imaging of salivary gland tumours, are to determine the proportion of patients with high PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancer; and to determine if in vitro PSMA expression correlates to PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancers. The hypotheses of this study are that there is high PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancers; and that in vitro PSMA expression correlates to PSMA-ligand uptake on Ga-68 PSMA imaging.